Trials / Completed
CompletedNCT03532711
Potential Predictive Biomarkers in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer
A Study to Characterize and Evaluate Biomarkers of Chemotherapy in Patients With Metastatic Colorectal Cancer In The First-line Setting
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 264 (actual)
- Sponsor
- Fudan University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Chemoresistance remains an obstacle in treating people with metastatic colorectal cancer (mCRC). Studying samples of blood and tumor tissue in the laboratory from patients with mCRC receiving chemotherapy may help doctors understand the effect of chemotherapy on biomarkers. It may also help doctors predict how patients will respond to treatment. In this study, we aimed to evaluate biomarkers in chemotherapy regimens for first-line chemotherapy for mCRC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fluorouracil | chemotherapy treated patients |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2016-06-30
- Completion
- 2016-12-31
- First posted
- 2018-05-22
- Last updated
- 2018-05-22
Source: ClinicalTrials.gov record NCT03532711. Inclusion in this directory is not an endorsement.